A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health
Clinical trial NCT07425821 · RECRUITING
Trial details
- NCT number
- NCT07425821
- Sponsor
- International AIDS Vaccine Initiative
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2027-11-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.